DISORDERS OF BLOOD AGGREGATION STATE REGULATION SYSTEM IN ONCOLOGICAL PATIENTS
Keywords:
cancer, hemostasis, thrombosisAbstract
Thrombosis and cancer are connected with a bilateral сlinical correlation. Venous thromboembolism can occur to be the only clinical sign of unrevealed cancer. On the other side, in patients with diagnosed cancer at any stage thrombosis complications may occur. Tumor produce own procoagulation substances and also define increasing of coagulation activity of blood. Disorders of coagulation system of oncology patients need early correction. Risk of thrombosis after surgical operations increases, in gynecology it comprises 30 %.
References
Тарабрин О. А. Опасность тромбоэмболических осложнений у онкологических больных / О. А. Тарабрин, И. И. Тютрин // Материалы 3-й конференции онкологов России. – Томск : Изд-во ТГУ, 1993 . – С. 86–88.
Levine M. N. Thrombosis in cancer patients / M. N. Levine, F. Rickles, A. K. Kakkar // American Society of Clinical Oncology, 38 Annual Meeting, Orlando. – 2002, May 18–21. – P. 57–60.
Trousseau A. Phlegmasia alba dolens. Lectures on clinical medicine, delivered at the Hotel- Dieu / A. Trousseau. – Paris ; London : New Sydenham Society, 1872. – P. 281–295.
Рак и тромбоз / В. П. Балуда, М. В. Балуда, И. К. Тлепшуков, А. Ф. Цыб. – М. ; Обнинск, 2001. – 153 с.
Green K. B. Hypercoagulability in cancer / K. B. Green, R. L. Silverstein // Hemat. Oncol. Clin. North. Am. – 1996. – Vol. 10. – P. 499–530.
Hillen H. F. Thrombosis in cancer patients / H. F. Hillen // ESMO, Ann. Oncol. – 2000. – Vol. 11 (Suppl. 3). – P. 273–276.
Тарабрин О. А. Использование бемипарина в комплексной профилактике и коррекции нарушений гемокоагуляции у больных с раком тела матки на этапах хирургического лечения / О. А. Тарабрин, А. В. Туренко, С. С. Щербаков // Здоровье женщины. – 2010. – № 4 (50). – С. 130–133.
Venous thromboembolism and cancer / J. A. Baron, G. Gridley, E. Weiderpass [et al.] // Lancet. – 1998. – Vol. 351. – P. 1077–1080.
Monitoring of coagulation in patients after abdominal cancer surgery / O. Tarabrin, V. Suslov, S. Kalinchuk [et al.] // Critical care. – 2011. – Vol. 15, Suppl. 1. – P. 153.
Importance of findings on the initial evaluation for cancer in patients with symptomatic idiopathic deep venous thrombosis / G. Comuz, S. D. Pearson, M. Creager [et al.] // Ann. Intern. Med. – 1996. – Vol. 125. – P. 785–793.
Diagnosis of cancer-associated vascular disorders / J. E. Naschitz, D. Yeshurun, S. Eldar [et al.] // Cancer. – 1996. – Vol. 77. – P. 1759–1767.
Deep vein thrombosis and the incidence of subsequent symptomatic cancer / P. Prandoni, A. W. Lensing, H. R. Buller [et al.] // New Engl. J. Med. – 1992. – Vol. 327. – P. 1128–1133.
Prandoni P. Antithrombotic strategies in patients with cancer / P. Prandoni // Thrombosis and Haemostasis. – 1997. – Vol. 78. – P. 141–144.
The risk of diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism / M. T. Sorensen, L. Mellemkjaer, F. H. Steffensen [et al.] // N. Engl. J. Med. – 1998. – Vol. 338. – P. 1169–1173.
Шитикова А. С. Тромбоцитарный гемостаз / А. С. Шитикова. – СПб., 2000. – 158 с.
Agnelii G. Venous thromboembolism and cancer: two-way clinical association / G. Agnelii // Thrombosis and Haemostasis. – 1997. – Vol. 78, N l. – P. 117–120.
Randomized double-blind study to compare the efficacy and safety of postoperative fondaparinux (Arixtra) and preoperative dalteparin in the prevention of venous thromboembolism after high risk abdominal surgery: the PEGASUSStudy (abstract) / G. Agnelii, D. Bergqvist, A. Cohen [et al.] // Blood. – 2003 . – Vol. 102. – P. 15a.
Risk of recurrent thromboembolism in patients with the factor V Leiden (FVR5060)mutation: effect of warfarin and prediction by precipitating factors. East Angian Thrombophilia Study Group / C. Baglin, K. Broun, R. Luddington, T. Baglin // Brit. J. Haemotol. – 1998. – Vol. 100. – P. 764–768.
Predictors of survival after deep vein thrombosis and pulmonary embolism: a populationbased, cohort study / J. A. Heit, M. D. Silverstein, D. N. Mohr [et al.] // Arch. Intern. Med. – 1999. – Vol. 159. – P. 445–453.
Undiagnosed malignancy in patients with deep-vein thrombosis / R. J. Hettiarachi, J. Lok, M. H. Prins [et al.] // Cancer. – 1998. – Vol. 83. – P. 180–185.
Residual venous thrombosis as predictive factor of recurrent venous thromboembolism / P. Prandoni, A. Lensing, M. H. Prins [et al.] // Ann. Intern. Med. – 2002. – Vol. 137. – P. 955–960.
Ultrasonography of contralateral veins in patients with unilateral deep-vein thrombosis / P. Prandoni, A. Lensing, A. Piccioli [et al.] // Lancet. – 1998. – Vol. 352. – P. 786.
Prandoni P. Cancer and venous thromboembolism: an overview / P. Prandoni, A. Piccioli, A. Georama // Hematologica. – 1999. – Vol. 84. – P. 437–445.
Occult cancer in patients with bilateral deep-vein thrombosis / A. Ranee, J. Emmerich, C. Glued [et al.] // Lancet. – l997. – Vol. 350. – P. 1448–1449.
Risk factors of deep-vein thrombosis and pulmonary embolism: a population-based, control study / J. A. Heit, M. D. Silverstein, D. N. Mohr [et al.] // Arch. Intern. Med. – 2000. – Vol. 160. – P. 809–815.
Levine M. N. Thrombosis and cancer / M. N. Levine, A. Y. Lee, A. K. Kakkar // American Society of Clinical Oncology, 41 Annual Meeting May 13–17. – 2005. – P. 748–777.
Coagulation and cancer: implications for diagnosis and management / M. F. Loreto, D. E. Martinis, M. P. Corsi [et al.] // Pathology oncology research. – 2000. – Vol. 6, N 4. – P. 302–312.
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis / P. Prandoni, A. Lensing, A. Piccioli [et al.] // Blood. – 2002. – Vol. 100. – P. 3484–3488.
Smorenburg S. M. Should patients with venous thromboembolism and cancer be treated differently? / S. M. Smorenburg, B. A. Hutten, M. N. Prins // Haemostasis. – 1999. – Vol. 29 (suppl.). – P. 91–97.
Sallah S. Venous thrombosis in patients with solid tumors: determination of frequency and characteristic / S. Sallah, J. Y. Wan, N. P. Nquyen // Thromb. Haemost. – 2002. – Vol. 87. – P. 575–579.
Deitcher S. R. Primary prevention of venous thromboembolic events (VTE) in the cancer patient: an American survey study / S. R. Deitcher // American Society of Clinical Oncology, 41 Annual Meeting May 13–17. – 2005. – P. 746.
Dvorak H. F. Abnormalities of hemostasis in malignant disease / H. F. Dvorak // Thrombosis and Haemostasis / eds. W. Colman, J. Hirsh, V. J. Marder, E. W. Salzman. – 1994. – P. 1238–1254.
Frequency and prognostic significance of DVT with specific neoplasms / D. Elsayegh, A. Elhaij, L. Emmer, T. Teryanian // American Society of Clinical Oncology, 41 Annual Meeting May 13–17. – 2005. – P. 781.
Incidence of thrombosis in gastro-esophageal cancer; a cohort study of 761 patients / M. Tesselaar, N. Steeghs, F. Rosendaal, S. Osanto // American Society of Clinical Oncology, 41 Annual Meeting May 13–17. – 2005. – P. 779.
Evaluation and management of the cancer patients with thrombosis / K. A. Bauer, M. Levine // American Society of Clinical Oncology. – 1999. – P. 223–235.
Coagulation and cancer: implications for diagnosis and management / M. F. Loreto, D. E. Martinis, M. P. Corsi [et al.] // Pathology oncology research. – 2000. – Vol. 6, N 4. – P. 302–312.
Бокарев И. Н. Венозный тромбоэмболизм и тромбоэмболия легочной артерии / И. Н. Бокарев, Л. В. Попова. – М. : Мединформ-агентство, 2005. – 208 с.
Bromberg M. E. Cancer and blood coagulation: molecular aspects / M. E. Bromberg, M. Cappello // Cancer. – 1999. – Vol. 3. – P. 132–138.
Falanga A. Pathophysiology of the thrombotic state in the cancer patients / A. Falanga, F. R. Tickles // Semin Thromb Haemostas. – 1999. – Vol. 25. – P. 173–182.
Levine M. N. Thrombosis and cancer / M. N. Levine, A. Y. Lee, A. K. Kakkar // American Society of Clinical Oncology, 41 Annual Meeting May 13–17. – 2005. – P. 748–777.
Arcelus J. I. Recognizing the risk of VTE in surgical patients / J. I. Arcelus // Optimizing VTE Management in surgical patients : International Surgical Thrombosis Meeting : abstract. – Greece, 2007.
Cicco M. The prothrombotic state in cancer: pathogenic mechanisms / M. Cicco // Crit Rev Oncol Hematol. – 2004, Jun. – Vol. 50 (3). – P. 187–196.
Eilertsen K. E. Tissue factor: pathophysiology and cellular biology / K. E. Eilertsen, B. Osterud // Bood Coagul. Fibrinolysis. – 2004. – Vol. 15 (7). – P. 521–538.
Rickles F. A мolecular basis for the relationship between thrombosis and cancer / F. Rickles, A. Falanga // Thromb. Res. – 2001. – Vol. 102. – P. 215–224.
Lip J. A. Cancer and the prothrombotic state / J. A. Lip, B. S. Chin, A. D. Blann // Lancet Oncol. – 2002 , Jan. – Vol. 3 (1). – P. 27–34.
Петрищев Н. Н. Физиология и патофизиология эндотелия / Н. Н. Петрищев, Т. Д. Власов // Дисфункция эндотелия. Причины, механизмы, фармакологическая коррекция / под ред. Н. Н. Петрищева. – СПб., 2003. – С. 4–38.
Сравнительное изучение эффективности профилактического применения нефракционированного и низкомолекулярных гепаринов при хирургическом лечении онкологических больных / А. Н. Шилова, С. А. Ходоренко, П. А. Воробьев [и др.] // Клиническая геронтология. – 2002. – Т. 8, кн. 4. – С. 11–17.
Cancer and venous thromboembolism / A. Piccioli, P. Prandoni, B. M. Ewenstein, S. Z. Goldhaber // Am. Heart J. – 1996. – Vol. 132. – P. 850–855.
Falanga A. Venous thromboembolism in oncology / A. Falanga, A. Vignoli // Eksp. Oncol. – 2004. – Vol. 26 (1). – P. 11–14.
Панченко Е. П. Тромбозы в кардиологии. Механизмы развития и возможности терапии / Е. П. Панченко, А. Б. Добровольский. – М. : Спорт и культура, 1999. – 464 с.
Becker R. C. Antithrombotic therapy / R. C. Becker, D. J. Fintel, D. Green. – 2nd ed. – U. S. A., 2002. – 352 р.
Mechanism of antithrombin III inhibition of factor Vila/tissue factor activity on cell surfaces. Comparison with tissue factor pathway inhibitor/factor Xa-induced inhibition of factor Vila/tissue factor activity / L. V. M. Rao, O. Norfang, A. D. Hoang, U. R. Pendurthi // Blood. – 1995. – Vol. 85. – P. 121–129.
Newer concepts of blood coagulation / H. R. Roberts, D. M. Monroe, J. A. Oliver [et al.] / / Haemophilia. – 1998. – Vol. 4. – P. 331–334.
Disseminated intravascular coagulation in solid tumors: clinical and pathologic study / S. Sallah, J. Y. Wan, N. P. Nquyen [et al.] // Thromb. Haemost. – 2001, Sep. – Vol. 86 (3). – P. 828–833.
Кузник Б. И. Физиология и патология системы крови / Б. И. Кузник. – Чита, 2004. – 230 с.
Colman R. W. Biologic activities of the contact factors in vivo / R. W. Colman // Thromb. Haemost. – 1999. – Vol. 82. – P. 1568–1577.
